Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Tyrosine Kinase Inhibitor
 Bactericidal Topical Antibiotics
 Drugs Abuse Testing Market
March 2018   e-Newsletter Archives    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
MEDICAL FAIR ASIA 2018
News
Biogen to buy Pfizer's neurology drug in deal nearing $600 million...
Janssen Announces U.S. FDA Breakthrough Therapy Designation...
Seattle Genetics and Astellas Receive FDA Breakthrough Therapy...
 
Press Releases
Daiichi Sankyo's HER2-Targeting Antibody Drug Conjugate DS-8201...
Mylan and Biocon Receive Approvals from the European Commission...
Do You Know Your "Lean Lab" Terminology? Download...
 
Events
03 - 05 April 2018
Immune Profiling World Congress Washington
09-10 April 2018
Digital Pharma Japan
09 - 11 April 2018
Clinical Trial Collaborations
Articles
  Cancer Stem Cell (CSC) Inhibitors
Prashant S Kharkar Associate Professor, SPP School of Pharmacy and Technology Management, SVKM's NMIMS (Deemed-to-be-University).
Cancer is an incurable disease. Cancer relapse is credited to a population of cells, called as Cancer Stem Cells (CSCs). These drug-resistant cells possess stem-like characters such as pluripotency, self-renewal...
EVA
Techno Trends
  Cipher Pharmaceuticals Launches a Novel Bactericidal Topical...
  Breakthrough Therapy Lenvima/Keytruda Combo Treats Patients...
FPS
Projects
  Paragon Bioservices Announces New commercial Manufacturing...
  Novo Nordisk Plans US$65m Expansion at Its 264-Acre Campus...
Vetter Pharma
Industry Reports
  Drugs of Abuse Testing Market - Global Industry Analysis 2012 - 2016...
CPhI & P-MEC China 2018
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555